SILVER SPRING, MD — The FDA gives full approval for Moderna’s COVID-19 vaccine in children aged 6 months through 11 years who ...

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

The Chinese national claimed that it was a case of mistaken identity as his surname was common in China. He was produced in ...

The Stratus COVID-19 variant, which includes the XFG and XFG.3 strains, currently accounts for around 30 per cent of COVID-19 ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...

A federal trial is underway for a Utah plastic surgeon accused of throwing away vaccinations but still handing out COVID-19 ...

Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

The US Food and Drug Administration granted full approval to Moderna's Spikevax vaccine and the company is hopeful of releasing the updated version for the 2025-26 flu season ...